Founded in Granbury, Texas, Revolver Brewing has built its reputation on pushing boundaries while staying true to its roots.

The cost of ignoring employee stress is high—from absenteeism to quiet quitting and turnover. Proactive support, on the other ...

Not unlike Regeneron’s acquisition of 23andMe, Predictive Oncology’s AI-driven breakthroughs reflect a broader transformation in life sciences. The integration of genomics, machine learning, and ...

CAMBRIDGE, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, ...

Integration of Abbott’s glucose-ketone sensor with the twiist™ AID System aims to enhance early identification of rising ketones to detect the risk of diabetic ketoacidosis (DKA)1 MANCHESTER, N.H., ...

BetterLife announced on July 16, 2024, that it had amended its past Management Information Circulars (“MIC”) to correct disclosures of beneficial ownership by its Chief Executive Officer, Dr. Ahmad ...

Corporate overview Presentation Date: Thursday, June 5, 2025 Presentation Time: 11:05 a.m. ET Webcast: Click Here About Sofwave Medical Sofwave Medical Ltd. has implemented an innovative approach to ...

The notice from Nasdaq indicates that the Company is in compliance with the Nasdaq Capital Market's listing requirements and the Company's common stock will continue to be listed and traded on Nasdaq.

(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy ® (semaglutide), which includes ...

A webcast of the presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com, and will be available for 30 days.

EVX-01 is designed with Evaxion’s AI-Immunology™ platform and tailored to target the unique tumor profile and immune characteristics of each individual patient. It engages the patient's immune system ...

An independent panel of judges selected Jason Matuszewski, CEO of BioStem Technologies, as one of 25 finalists, recognizing his entrepreneurial spirit, purpose, growth, and lasting impact in creating ...